Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | May 31, 2024
Distillery Therapeutics

Inhibiting ACOX1 for obesity

BioCentury | Sep 14, 2017
Strategy

Numerate’s Intelligence

How Numerate’s AI tackles translational questions with tiny data sets
BioCentury | Nov 15, 2016
Distillery Therapeutics

Endocrine / Metabolic

BioCentury | Nov 6, 2014
Targets & Mechanisms

Greasing insulin

BioCentury | Nov 6, 2014
Distillery Therapeutics

Indication: Endocrine/metabolic disease

BioCentury | Aug 14, 2014
Distillery Therapeutics

Indication: Endocrine/metabolic disease

BioCentury | Mar 8, 2012
Targets & Mechanisms

An obesity angle for GPR120

BioCentury | Mar 8, 2012
Distillery Therapeutics

Indication: Autoimmune Disease

BioCentury | Mar 8, 2012
Distillery Therapeutics

Indication: Endocrine/metabolic disease

Items per page:
1 - 10 of 12
Help Center
Username
Request a Demo
Request Training
Ask a Question